3.4
NF-KB-afhankelijke signaalroute
De transcriptiefactor NF-KB werd in 1986 ontdekt in het laboratorium van Nobelprijswinnaar professor David Baltimore, vanwege zijn interactie met de v…
NF-κB proteins are transcription factors that are involved in many crucial cellular functions such as immune cell activation, cell adhesion, antimicrobial response, and cell cycle regulation.
In the resting state, the NF-κB exists as a heterodimer directly bound to an inhibitory protein called IκBɑ. IκBɑ suppresses the activity of NF-κB as a transcriptional activator.
The NF-κB-dependent signaling pathway is activated upon binding of an appropriate ligand to its corresponding cell-surface receptor on the target cell.
For example, the pathway can be triggered by binding of tumor necrosis factor-ɑ to the TNF receptor, binding of interleukin 1 to the IL1 receptor, or binding of pathogens to toll-like receptors.
This ligand-receptor binding results in the activation of a protein complex, IκB kinase, consisting of three subunits, ɑ, β, and γ.
The activated kinase then phosphorylates the IkB protein leading to its ubiquitination.
The marked IκB protein then undergoes immediate degradation in the proteasome.
As a result, the NF-κB dimer is released from IκB and is free for its translocation to the nucleus where it can activate the expression of a number of target genes.
One of the target genes activated by NF-κB is the gene that encodes the IκBɑ protein. Upon its increased expression, IκBɑ assists in regulating the NF-κB-dependent Signaling Pathway via a negative feedback loop.
The NF-κB-dependent signaling pathway acts to control a broad range of biological processes, including innate and adaptive immunity and inflammatory stress responses.
Due to its pivotal role in immune as well as inflammatory responses in animals, dysregulation of NF-κB can lead to various types of cancers, as well as several inflammatory diseases, such as arthritis and asthma.
View the full transcript and gain access to JoVE Core videos
Q1: What is NF-κB and what are its main cellular functions?
NF-κB is a transcription factor that regulates expression of over 100 genes essential for immune and inflammatory responses. It controls crucial cellular functions including immune cell activation, cell adhesion, antimicrobial response, and cell cycle regulation. NF-κB also regulates cell proliferation, apoptosis, and plays diverse roles in the nervous system such as learning and memory.
Q2: How does IκBα regulate NF-κB activity in resting cells?
In resting cells, NF-κB exists as a heterodimer bound to the inhibitory protein IκBα, which suppresses its transcriptional activity. IκBα masks the nuclear localization signals of NF-κB, keeping it inactive in the cytoplasm. This inhibitory mechanism prevents NF-κB from entering the nucleus and activating target genes until an appropriate signal is received.
Q3: What triggers activation of the NF-κB signaling pathway?
The NF-κB pathway activates when ligands bind to cell-surface receptors, such as tumor necrosis factor-α binding to TNF receptor, interleukin-1 binding to IL1 receptor, or pathogens binding to toll-like receptors. These ligand-receptor interactions activate the IκB kinase complex, which phosphorylates IκBα, leading to its ubiquitination and proteasomal degradation, releasing NF-κB for nuclear translocation.
Q4: What happens to NF-κB after IκBα is degraded?
Once IκBα is degraded in the proteasome, the NF-κB dimer is released and free to translocate to the nucleus. In the nucleus, NF-κB acts as a transcriptional activator, binding to DNA and activating expression of target genes. This allows the cell to mount appropriate physiological responses to external stimuli such as pathogens or reactive oxygen species.
Q5: How does NF-κB regulate itself through negative feedback?
NF-κB activates the gene encoding IκBα protein as one of its target genes. Upon increased expression, newly synthesized IκBα binds to NF-κB in the nucleus, causing it to exit and return to the cytoplasm. This negative feedback loop prevents excessive NF-κB signaling and helps maintain cellular homeostasis by limiting the duration and intensity of the immune response.
Q6: What diseases result from dysregulation of NF-κB signaling?
Dysregulation of NF-κB can lead to various cancers and inflammatory diseases such as arthritis and asthma. Additionally, pathogens like HIV, HPV, and Yersinia pestis exploit or interfere with the NF-κB signaling pathway to evade host defense mechanisms. Because of its diverse roles in animals, the NF-κB signaling pathway and associated diseases make it an excellent therapeutic target.
Q7: Why is NF-κB considered a central mediator of immune responses?
NF-κB regulates expression of genes essential for both innate and adaptive immune responses as well as inflammatory stress responses. It controls activation of immune cells, antimicrobial defenses, and inflammatory signaling. Since its discovery in 1986, over three decades of research has revealed that NF-κB coordinates multiple aspects of immune defense, making it central to how animals respond to pathogens and cellular stress.